TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis-Reference-Cited by-同舟云学术

TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis

Published:2019-02 Issue: Volume:12 Page:41-52
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Cartland Siân P.,Genner Scott W.,Martínez Gonzalo J.,Robertson Stacy,Kockx Maaike,Lin Ruby CY.,O'Sullivan John F.,Koay Yen Chin,Manuneedhi Cholan Pradeep,Kebede Melkam A.,Murphy Andrew J.,Masters Seth,Bennett Martin R.,Jessup Wendy,Kritharides Leonard,Geczy Carolyn,Patel Sanjay,Kavurma Mary M.

Funder

University of Sydney

Heart Foundation of Australia Career Development Award

Perpetual IMPACT Philanthropy

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference49 articles.

1. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice;Aiello;Arterioscler. Thromb. Vasc. Biol.,1999

2. Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms for PDGF-BB-mediated VSMC proliferation and migration;Azahri;J. Cell. Biochem.,2012

3. TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE-/- mice;Cartland;PLoS One,2014

4. Comparative evaluation of TRAIL, FGF-2 and VEGF-A-induced angiogenesis in vitro and in vivo;Cartland;Int. J. Mol. Sci.,2016

5. Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice;Cartland;Sci. Rep.,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease;Biomolecules;2024-09-04

2. The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies;Biology;2024-07-15

3. Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation;Clinical Immunology;2024-07

5. Biomimetic and inflammation-targeted nanoparticles for rheumatoid arthritis therapy via M1-macrophages apoptosis and polarization;Materials & Design;2024-03